284 related articles for article (PubMed ID: 12847102)
21. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
22. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
[TBL] [Abstract][Full Text] [Related]
23. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
[TBL] [Abstract][Full Text] [Related]
24. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice.
Kosters A; Frijters RJ; Schaap FG; Vink E; Plösch T; Ottenhoff R; Jirsa M; De Cuyper IM; Kuipers F; Groen AK
J Hepatol; 2003 Jun; 38(6):710-6. PubMed ID: 12763362
[TBL] [Abstract][Full Text] [Related]
25. A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux.
Sparrow CP; Baffic J; Lam MH; Lund EG; Adams AD; Fu X; Hayes N; Jones AB; Macnaul KL; Ondeyka J; Singh S; Wang J; Zhou G; Moller DE; Wright SD; Menke JG
J Biol Chem; 2002 Mar; 277(12):10021-7. PubMed ID: 11790770
[TBL] [Abstract][Full Text] [Related]
26. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
[TBL] [Abstract][Full Text] [Related]
27. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
28. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice.
Terasaka N; Hiroshima A; Koieyama T; Ubukata N; Morikawa Y; Nakai D; Inaba T
FEBS Lett; 2003 Feb; 536(1-3):6-11. PubMed ID: 12586329
[TBL] [Abstract][Full Text] [Related]
29. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists.
Levin N; Bischoff ED; Daige CL; Thomas D; Vu CT; Heyman RA; Tangirala RK; Schulman IG
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):135-42. PubMed ID: 15539622
[TBL] [Abstract][Full Text] [Related]
30. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.
Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F
J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
32. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
33. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
Laffitte BA; Repa JJ; Joseph SB; Wilpitz DC; Kast HR; Mangelsdorf DJ; Tontonoz P
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):507-12. PubMed ID: 11149950
[TBL] [Abstract][Full Text] [Related]
34. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.
Endo-Umeda K; Aoyama A; Shimizu M; Ishikawa M; Hashimoto Y; Yamada S; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():136-148. PubMed ID: 28736297
[TBL] [Abstract][Full Text] [Related]
35. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice.
Kruit JK; Plösch T; Havinga R; Boverhof R; Groot PH; Groen AK; Kuipers F
Gastroenterology; 2005 Jan; 128(1):147-56. PubMed ID: 15633131
[TBL] [Abstract][Full Text] [Related]
36. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
[TBL] [Abstract][Full Text] [Related]
37. Pravastatin Modulate Niemann-Pick C1-Like 1 and ATP-Binding Cassette G5 and G8 to Influence Intestinal Cholesterol Absorption.
Kawase A; Hata S; Takagi M; Iwaki M
J Pharm Pharm Sci; 2015; 18(5):765-72. PubMed ID: 26670369
[TBL] [Abstract][Full Text] [Related]
38. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.
Mitro N; Vargas L; Romeo R; Koder A; Saez E
FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145
[TBL] [Abstract][Full Text] [Related]
39. 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes.
Kase ET; Andersen B; Nebb HI; Rustan AC; Thoresen GH
Biochim Biophys Acta; 2006 Dec; 1761(12):1515-22. PubMed ID: 17055780
[TBL] [Abstract][Full Text] [Related]
40. Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells.
Hoekstra M; Kruijt JK; Van Eck M; Van Berkel TJ
J Biol Chem; 2003 Jul; 278(28):25448-53. PubMed ID: 12704191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
